100 related articles for article (PubMed ID: 6819645)
21. Effects of three trans isomers of eicosapentaenoic acid on rat platelet aggregation and arachidonic acid metabolism.
Loï C; Chardigny JM; Berdeaux O; Vatèle JM; Poullain D; Noël JP; Sébédio JL
Thromb Haemost; 1998 Oct; 80(4):656-61. PubMed ID: 9798987
[TBL] [Abstract][Full Text] [Related]
22. Influence of thiofedrine on platelet aggregation, intraplatelet cyclic cAMP and malondialdehyde in rats.
Qu YZ; Li XX
Methods Find Exp Clin Pharmacol; 1994 May; 16(4):253-6. PubMed ID: 8051984
[TBL] [Abstract][Full Text] [Related]
23. The influence of chronic ethanol administration on adriamycin-induced nephrotic syndrome in rats.
Tesar V; Zima T; Poledne R; Stejskalová A; Stípek S; Tĕmínová J
Alcohol Alcohol; 1995 Jan; 30(1):47-53. PubMed ID: 7748275
[TBL] [Abstract][Full Text] [Related]
24. Evidence against a platelet cyclooxygenase defect in uraemic subjects on chronic haemodialysis.
Bloom A; Greaves M; Preston FE; Brown CB
Br J Haematol; 1986 Jan; 62(1):143-9. PubMed ID: 3080018
[TBL] [Abstract][Full Text] [Related]
25. Increased platelet prostaglandin and thromboxane synthesis in diabetes mellitus.
Halushka PV; Rogers RC; Loadholt CB; Wohltman H; Mayfield R; McCoy S; Colwell JA
Horm Metab Res Suppl; 1981; 11():7-11. PubMed ID: 7033097
[TBL] [Abstract][Full Text] [Related]
26. Effects of endothelin-1 on aggregation of normal and uremic platelets.
Pawlak K; Małyszko JS; Małyszko J; Myśliwiec M
Pol J Pharmacol; 1996; 48(2):185-90. PubMed ID: 9112649
[TBL] [Abstract][Full Text] [Related]
27. Platelet arachidonic acid metabolism in patients with cardiovascular disorders.
Ghigo D; Treves S; Bussolino F; Libero L; Orzan F; Bazzan M; Pannocchia A; Tamponi G; Bosia A
Biomed Biochim Acta; 1988; 47(10-11):S299-302. PubMed ID: 3248116
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of human platelet cyclo-oxygenase activity by sulfinpyrazone and three of its metabolites.
Del Maschio A; Livio M; Cerletti C; De Gaetano G
Eur J Pharmacol; 1984 Jun; 101(3-4):209-14. PubMed ID: 6432556
[TBL] [Abstract][Full Text] [Related]
29. [Chemiluminescence of thrombocytes in thrombin-induced aggregation].
Samal' AB; Cherenkevich SN; Khmara NF
Vopr Med Khim; 1984; 30(6):12-5. PubMed ID: 6442039
[TBL] [Abstract][Full Text] [Related]
30. Lytic solution of platelet-rich plasma clots potentiated platelet response to agonists by action on Ca2+ homeostasis.
Liao CL; Zou QJ
Zhongguo Yao Li Xue Bao; 1993 May; 14(3):214-8. PubMed ID: 8237394
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological characterization of 2NTX-99 [4-methoxy-N1-(4-trans-nitrooxycyclohexyl)-N3-(3-pyridinylmethyl)-1,3-benzenedicarboxamide], a potential antiatherothrombotic agent with antithromboxane and nitric oxide donor activity in platelet and vascular preparations.
Buccellati C; Sala A; Rossoni G; Capra V; Rovati GE; Di Gennaro A; Folco G; Colli S; Casagrande C
J Pharmacol Exp Ther; 2006 May; 317(2):830-7. PubMed ID: 16399881
[TBL] [Abstract][Full Text] [Related]
32. A Thrombelastograph whole blood assay for clinical monitoring of NSAID-insensitive transcellular platelet activation by arachidonic acid.
Carroll RC; Craft RM; Chavez JJ; Snider CC; Bresee SJ; Cohen E
J Lab Clin Med; 2005 Jul; 146(1):30-5. PubMed ID: 16025089
[TBL] [Abstract][Full Text] [Related]
33. Evaluation of dose-related effects of aspirin on platelet function: results from the Aspirin-Induced Platelet Effect (ASPECT) study.
Gurbel PA; Bliden KP; DiChiara J; Newcomer J; Weng W; Neerchal NK; Gesheff T; Chaganti SK; Etherington A; Tantry US
Circulation; 2007 Jun; 115(25):3156-64. PubMed ID: 17562955
[TBL] [Abstract][Full Text] [Related]
34. The effect of streptozocin-induced diabetes on platelet aggregation as determined by impedance aggregometry and platelet secretion: a possible role for nitric oxide.
Judge S; Mammen E; Dunbar JC
J Assoc Acad Minor Phys; 1995; 6(3):100-4. PubMed ID: 7663098
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms underlying increased platelet reactivity in patients with peripheral arterial disease. Preliminary results.
Reininger CB; Boeger CA; Steckmeier B; Spannagl M; Scweiberer L
Int Angiol; 1999 Jun; 18(2):163-70. PubMed ID: 10424375
[TBL] [Abstract][Full Text] [Related]
36. Increased platelet sensitivity among individuals with aspirin resistance - platelet aggregation to submaximal concentration of arachidonic acid predicts response to antiplatelet therapy.
Guthikonda S; Mangalpally K; Vaduganathan M; Patel R; Delao T; Bergeron AL; Dong JF; Lev EI; Kleiman NS
Thromb Haemost; 2008 Jul; 100(1):83-9. PubMed ID: 18612542
[TBL] [Abstract][Full Text] [Related]
37. Inhibitory effect of tetrahydroberberine on platelet aggregation and thrombosis.
Xuan B; Wang W; Li DX
Zhongguo Yao Li Xue Bao; 1994 Mar; 15(2):133-5. PubMed ID: 8010106
[TBL] [Abstract][Full Text] [Related]
38. Low concentrations of lipid hydroperoxides prime human platelet aggregation specifically via cyclo-oxygenase activation.
Calzada C; Vericel E; Lagarde M
Biochem J; 1997 Jul; 325 ( Pt 2)(Pt 2):495-500. PubMed ID: 9230133
[TBL] [Abstract][Full Text] [Related]
39. [The studies on the mechanism of platelet activation induced by exogenous arachidonic acid with special reference to intraplatelet Ca2+ mobilization].
Koyama M
Hokkaido Igaku Zasshi; 1994 Jul; 69(4):1044-56. PubMed ID: 7959585
[TBL] [Abstract][Full Text] [Related]
40. Effects of dietary supplementation with arachidonic acid on platelet and renal function in patients with cirrhosis.
Pantaleo P; Marra F; Vizzutti F; Spadoni S; Ciabattoni G; Galli C; La Villa G; Gentilini P; Laffi G
Clin Sci (Lond); 2004 Jan; 106(1):27-34. PubMed ID: 12877651
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
